Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
by
Lefebvre, Catherine
, Robin, Geoffroy
, Soudan, Benoit
, Leroy-Martin, Brigitte
, Dewailly, Didier
, Decanter, Christine
, Leroy, Maryse
, Thomas, Patricia
, Lefebvre-Khalil, Valerie
in
Adult
/ Androstenedione - blood
/ Birth control
/ Body mass index
/ Care and treatment
/ Contraceptives, Oral - therapeutic use
/ Desogestrel - therapeutic use
/ Dosage and administration
/ Drug Administration Schedule
/ Drug Therapy, Combination
/ Embryo Transfer
/ Endocrinology
/ Ethinyl Estradiol - therapeutic use
/ Female
/ Fertilization in vitro
/ Fertilization in Vitro - methods
/ Follicle Stimulating Hormone - therapeutic use
/ Gonadotropin-Releasing Hormone - agonists
/ Health aspects
/ Humans
/ Infertility
/ Medicine
/ Medicine & Public Health
/ Oral contraceptives
/ Ovarian Hyperstimulation Syndrome - prevention & control
/ Ovulation Induction
/ Patient outcomes
/ Polycystic ovary syndrome
/ Polycystic Ovary Syndrome - blood
/ Polycystic Ovary Syndrome - diagnostic imaging
/ Polycystic Ovary Syndrome - drug therapy
/ Pregnancy
/ Pregnancy Rate
/ Prospective Studies
/ Recombinant Proteins - therapeutic use
/ Reproductive health
/ Reproductive Medicine
/ Stein-Leventhal syndrome
/ Testosterone - blood
/ Treatment Outcome
/ Triptorelin Pamoate - therapeutic use
/ Ultrasonography
/ Young Adult
2013
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
by
Lefebvre, Catherine
, Robin, Geoffroy
, Soudan, Benoit
, Leroy-Martin, Brigitte
, Dewailly, Didier
, Decanter, Christine
, Leroy, Maryse
, Thomas, Patricia
, Lefebvre-Khalil, Valerie
in
Adult
/ Androstenedione - blood
/ Birth control
/ Body mass index
/ Care and treatment
/ Contraceptives, Oral - therapeutic use
/ Desogestrel - therapeutic use
/ Dosage and administration
/ Drug Administration Schedule
/ Drug Therapy, Combination
/ Embryo Transfer
/ Endocrinology
/ Ethinyl Estradiol - therapeutic use
/ Female
/ Fertilization in vitro
/ Fertilization in Vitro - methods
/ Follicle Stimulating Hormone - therapeutic use
/ Gonadotropin-Releasing Hormone - agonists
/ Health aspects
/ Humans
/ Infertility
/ Medicine
/ Medicine & Public Health
/ Oral contraceptives
/ Ovarian Hyperstimulation Syndrome - prevention & control
/ Ovulation Induction
/ Patient outcomes
/ Polycystic ovary syndrome
/ Polycystic Ovary Syndrome - blood
/ Polycystic Ovary Syndrome - diagnostic imaging
/ Polycystic Ovary Syndrome - drug therapy
/ Pregnancy
/ Pregnancy Rate
/ Prospective Studies
/ Recombinant Proteins - therapeutic use
/ Reproductive health
/ Reproductive Medicine
/ Stein-Leventhal syndrome
/ Testosterone - blood
/ Treatment Outcome
/ Triptorelin Pamoate - therapeutic use
/ Ultrasonography
/ Young Adult
2013
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
by
Lefebvre, Catherine
, Robin, Geoffroy
, Soudan, Benoit
, Leroy-Martin, Brigitte
, Dewailly, Didier
, Decanter, Christine
, Leroy, Maryse
, Thomas, Patricia
, Lefebvre-Khalil, Valerie
in
Adult
/ Androstenedione - blood
/ Birth control
/ Body mass index
/ Care and treatment
/ Contraceptives, Oral - therapeutic use
/ Desogestrel - therapeutic use
/ Dosage and administration
/ Drug Administration Schedule
/ Drug Therapy, Combination
/ Embryo Transfer
/ Endocrinology
/ Ethinyl Estradiol - therapeutic use
/ Female
/ Fertilization in vitro
/ Fertilization in Vitro - methods
/ Follicle Stimulating Hormone - therapeutic use
/ Gonadotropin-Releasing Hormone - agonists
/ Health aspects
/ Humans
/ Infertility
/ Medicine
/ Medicine & Public Health
/ Oral contraceptives
/ Ovarian Hyperstimulation Syndrome - prevention & control
/ Ovulation Induction
/ Patient outcomes
/ Polycystic ovary syndrome
/ Polycystic Ovary Syndrome - blood
/ Polycystic Ovary Syndrome - diagnostic imaging
/ Polycystic Ovary Syndrome - drug therapy
/ Pregnancy
/ Pregnancy Rate
/ Prospective Studies
/ Recombinant Proteins - therapeutic use
/ Reproductive health
/ Reproductive Medicine
/ Stein-Leventhal syndrome
/ Testosterone - blood
/ Treatment Outcome
/ Triptorelin Pamoate - therapeutic use
/ Ultrasonography
/ Young Adult
2013
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
Journal Article
First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
2013
Request Book From Autostore
and Choose the Collection Method
Overview
Background
Morphological aspect of polycystic ovaries (PCO) is a very common finding in an IVF center population: this includes PCOS patients identified in 18–25% of the couples presenting with infertility and so called “sonographic PCO only” the prevalence of which has been estimated as high as 33% in asymptomatic patients. Finding the optimal first intention IVF protocol for polycystic ovaries patients is still challenging in order to improve the controlled ovarian hyperstimulation (COH) outcome while avoiding ovarian hyperstimulation syndrome (OHSS). It has been suggested that women with PCO would benefit from a longer period of pituitary down-regulation. The purpose of this study was to compare an extended duration of OCP pretreatment with a classic GnRH agonist protocol.
Methods
A single center prospective non-randomized study was performed from January 2009 to December 2010 in the Lille University Hospital including 113 women diagnosed with PCO(S) according to the Rotterdam ultrasonographic criteria and undergoing their first IVF attempt. Comprehensive hormonal and ultra-sonographic assessments were collected during COH in these patients. LH and androgen suppression and dynamics of follicular growth were compared between the two protocols as well as the COH outcome in terms of oocyte/embryo number and quality, implantation and pregnancy rates.
Results
No significant difference was observed between the two groups concerning dynamics of follicular growth and hormonal values. Clinical and ongoing pregnancy rates were significantly lower in the OCP group despite same oocyte and embryo quality. Nevertheless, the cumulative pregnancy rate did not differ between the two groups. The incidence of OHSS was not statistically significant.
Conclusions
Extended duration of OCP pretreatment, as a first intention IVF protocol for PCO patients, does not improve the pattern of follicular growth nor the oocyte and embryo quality.
Publisher
BioMed Central,BioMed Central Ltd
Subject
/ Contraceptives, Oral - therapeutic use
/ Desogestrel - therapeutic use
/ Drug Administration Schedule
/ Ethinyl Estradiol - therapeutic use
/ Female
/ Fertilization in Vitro - methods
/ Follicle Stimulating Hormone - therapeutic use
/ Gonadotropin-Releasing Hormone - agonists
/ Humans
/ Medicine
/ Ovarian Hyperstimulation Syndrome - prevention & control
/ Polycystic Ovary Syndrome - blood
/ Polycystic Ovary Syndrome - diagnostic imaging
/ Polycystic Ovary Syndrome - drug therapy
/ Recombinant Proteins - therapeutic use
This website uses cookies to ensure you get the best experience on our website.